REDHILL BIOPHARMA LTD. (RDHL) Gross profit 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual gross profit history from SEC filings — each fiscal year as reported.
$4.9MFY2024 · since FY2015: $3,000 → $4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $4.9M | +58.0% |
| FY2023 | $3.1M | -89.2% |
| FY2022 | $28.5M | -21.7% |
| FY2021 | $36.4M | +32.3% |
| FY2020 | $27.5M | +581.2% |
| FY2019 | $4.0M | -27.0% |
| FY2018 | $5.5M | +193.6% |
| FY2017 | $1.9M | +1762.4% |
| FY2016 | $101,000 | +3266.7% |
| FY2015 | $3,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →